Skip to the page

Data / Form D filings / TRACT Therapeutics, Inc.

TRACT Therapeutics, Inc.: Form D filing

TRACT Therapeutics, Inc., a biotechnology company in Chicago, IL, filed a Form D with the SEC in 2019. The latest, on April 3, 2019, reports $15 million sold of a $15 million offering to 1 investor.

Find out what TRACT Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
125 W. OAK STREET, SUITE D, Chicago, IL, 60610
Phone
(312) 324-8400
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1772729

The full lists. Form D filings in Illinois: 1,511 rows, $75.55, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 3, 2019New notice$15,000,000$15,000,000$01Mar 18, 2019sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Joseph LeventhalDirector
Peter CourossiExecutive Officer, Director
Gretchen JohnsonExecutive Officer, Director
Norbert RiedelDirector

Other biotechnology companies in Illinois that filed recently

Every Form D from the week of Apr 1, 2019 · All recent filings in Illinois · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what TRACT Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.